2024-11-12  10:00:00 PM Chg. +0.3700 Volume Bid10:01:18 PM Ask10:01:18 PM Market Capitalization Dividend Y. P/E Ratio
79.7600USD +0.47% 1.97 mill.
Turnover: 104.92 mill.
79.7900Bid Size: 300 80.5000Ask Size: 100 18.53 bill.USD - 43.11

Business description

Hologic, Inc. is a leading developer, manufacturer and supplier of premium diagnostic products, medical imaging systems and surgical products. The Company's core business units focus on diagnostics, breast health, GYN surgical, and skeletal health. With a unified suite of technologies and a robust research and development program, Hologic is dedicated to The Science of Sure.
 

Management board & Supervisory board

CEO
Stephen P. MacMillan
Management board
Erik Anderson, Monica Aguirre Berthelot, Scott Christensen, John M. Griffin, Lisa Hellmann, Paul Malenchini, Essex Mitchell, Karleen Oberton, Jennifer Schneiders, Jan Verstreken
Supervisory board
Stephen P. MacMillan, Sally W. Crawford, Charles J. Dockendorff, Scott Garrett, Ludwig N. Hantson, Nanaz Mohtashami, Namal Nawana, Christiana Stamoulis, Stacey D. Stewart, Amy M. Wendell
 

Company data

Name: Hologic Inc.
Address: 250 Campus Drive,Marlborough, Massachusetts 01752, USA
Phone: +1-508-263-2900
Fax: -
E-mail: info@hologic.com
Internet: www.hologic.com/
Industry: Healthcare
Sector: Healthcare Providers
Sub sector: Healthcare Providers
End of financial year: 09-30
Free Float: -
IPO date: 1990-03-09

Investor relations

Name: Ryan Simon
IR phone: +1-858-410-8514
IR Fax: -
IR e-mail: ryan.simon@hologic.com

Main Shareholders

Others
 
52.45%
Vanguard Group
 
11.86%
BlackRock Inc.
 
10.39%
T. Rowe Price Investment Management, Inc.
 
9.45%
State Street Corporation
 
4.75%
GEODE CAPITAL MANAGEMENT LLC
 
2.39%
VICTORY CAPITAL MANAGEMENT INC
 
2.16%
MACQUARIE GROUP LTD
 
1.81%
RENAISSANCE TECHNOLOGIES LLC
 
1.72%
Others
 
3.02%